<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="reopening SARS-CoV-2 schools transmission page-count: The unknown correlates of severe" exact="acute" post="respiratory syndrome coronavirus 2 transmission One of the key"/>
 <result pre="SARS-CoV-2 schools transmission page-count: The unknown correlates of severe acute" exact="respiratory" post="syndrome coronavirus 2 transmission One of the key characteristics"/>
 <result pre="schools transmission page-count: The unknown correlates of severe acute respiratory" exact="syndrome" post="coronavirus 2 transmission One of the key characteristics of"/>
 <result pre="coronavirus 2 transmission One of the key characteristics of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is high transmissibility which,"/>
 <result pre="2 transmission One of the key characteristics of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is high transmissibility which, fueled"/>
 <result pre="transmission One of the key characteristics of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is high transmissibility which, fueled by"/>
 <result pre="[1]. Within a period of four months, the resulting coronavirus" exact="disease" post="of 2019 (COVID-19) was declared a pandemic by the"/>
 <result pre="coronaviruses that can be fatal for humans, the first severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV-1) of 2002–2003 and the Middle"/>
 <result pre="that can be fatal for humans, the first severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV-1) of 2002–2003 and the Middle East"/>
 <result pre="can be fatal for humans, the first severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV-1) of 2002–2003 and the Middle East respiratory"/>
 <result pre="respiratory syndrome coronavirus (SARS-CoV-1) of 2002–2003 and the Middle East" exact="respiratory" post="syndrome coronavirus of 2012, the origin of SARS-CoV-2 is"/>
 <result pre="syndrome coronavirus (SARS-CoV-1) of 2002–2003 and the Middle East respiratory" exact="syndrome" post="coronavirus of 2012, the origin of SARS-CoV-2 is thought"/>
 <result pre="Syrian hamsters, with some of these animal species (rhesus macaques," exact="juvenile" post="cats and hamsters) displaying mild-to-moderate clinical disease [7–13]. In"/>
 <result pre="species (rhesus macaques, juvenile cats and hamsters) displaying mild-to-moderate clinical" exact="disease" post="[7–13]. In addition to these experimental infections, there have"/>
 <result pre="SARS-CoV-2 was thought to be spreading from person-to-person principally through" exact="respiratory" post="droplets generated during coughing and sneezing by infected individuals"/>
 <result pre="SARS-CoV-1, SARS-CoV-2 is transmitted before the onset of symptoms by" exact="symptomatic" post="persons and even by asymptomatic individuals [18,19]. Droplets of"/>
 <result pre="Droplets of saliva and other secretions are expelled from the" exact="respiratory" post="tract (the mouth and nose) not only during such"/>
 <result pre="trajectories of the epidemic in countries like Italy and Spain." exact="Respiratory" post="exhalations do not solely consist of mucosalivary droplets that"/>
 <result pre="agencies transmission model originally proposed by William F Wells for" exact="tuberculosis" post="in the 1930s had suggested. Instead, according to the"/>
 <result pre="1930s had suggested. Instead, according to the new model for" exact="respiratory" post="emissions, exhalations consist of clusters of varying in size"/>
 <result pre="School closures that are commonly suggested for mitigating epidemics of" exact="respiratory" post="infection were among the first social distancing measures implemented"/>
 <result pre="closures that are commonly suggested for mitigating epidemics of respiratory" exact="infection" post="were among the first social distancing measures implemented during"/>
 <result pre="the early phases of the outbreak, it became apparent that" exact="adult" post="pathogenesis varies with age and gender since older men"/>
 <result pre="with age and gender since older men with comorbidities (e.g.," exact="diabetes" post="or cardiovascular disease) were at higher risk for severe"/>
 <result pre="and gender since older men with comorbidities (e.g., diabetes or" exact="cardiovascular" post="disease) were at higher risk for severe illness from"/>
 <result pre="other end of the spectrum, children generally experience less severe" exact="disease" post="and have better prognosis after infection with SARS-CoV-2 [27],"/>
 <result pre="generally experience less severe disease and have better prognosis after" exact="infection" post="with SARS-CoV-2 [27], although a multisystem inflammatory syndrome (MIS-C)"/>
 <result pre="prognosis after infection with SARS-CoV-2 [27], although a multisystem inflammatory" exact="syndrome" post="(MIS-C) resembling Kawasaki Disease and toxic shock syndrome-like conditions"/>
 <result pre="SARS-CoV-2 [27], although a multisystem inflammatory syndrome (MIS-C) resembling Kawasaki" exact="Disease" post="and toxic shock syndrome-like conditions has been observed in"/>
 <result pre="although a multisystem inflammatory syndrome (MIS-C) resembling Kawasaki Disease and" exact="toxic shock" post="syndrome-like conditions has been observed in pediatric patients [28]."/>
 <result pre="mortality in children, including fewer underlying medical conditions and healthier" exact="respiratory" post="tracts because of less exposure to cigarette smoke and"/>
 <result pre="innate immune responses [31]. An alternative explanation for the generally" exact="benign" post="disease course in pediatric cases pertains to the less"/>
 <result pre="immune responses [31]. An alternative explanation for the generally benign" exact="disease" post="course in pediatric cases pertains to the less mature,"/>
 <result pre="cells. In agreement with this reasoning, data suggest that SARS-CoV-2" exact="infections" post="in children involve the upper rather than the lower"/>
 <result pre="reasoning, data suggest that SARS-CoV-2 infections in children involve the" exact="upper" post="rather than the lower respiratory tract, the typical site"/>
 <result pre="SARS-CoV-2 infections in children involve the upper rather than the" exact="lower" post="respiratory tract, the typical site of severe COVID-19 disease"/>
 <result pre="infections in children involve the upper rather than the lower" exact="respiratory" post="tract, the typical site of severe COVID-19 disease where"/>
 <result pre="the lower respiratory tract, the typical site of severe COVID-19" exact="disease" post="where ACE2 receptors are more abundant [29]. The role"/>
 <result pre="Singapore, Canada and South Korea, Davies et al. estimated that" exact="susceptibility to" post="infection in individuals under 20 years of age was"/>
 <result pre="and South Korea, Davies et al. estimated that susceptibility to" exact="infection" post="in individuals under 20 years of age was approximately"/>
 <result pre="SARS-CoV-2 transmission, particularly in settings where the transmissibility of subclinical" exact="infections" post="is low [33]. Studies from Israel and Greece that"/>
 <result pre="examined the dynamics of COVID-19 transmission within families showed significantly" exact="lower" post="infection rates in children compared with adults residing in"/>
 <result pre="the dynamics of COVID-19 transmission within families showed significantly lower" exact="infection" post="rates in children compared with adults residing in the"/>
 <result pre="a study of young children from northern France [36], SARS-CoV-2" exact="infection" post="was found to be largely mild or asymptomatic and"/>
 <result pre="line with previous studies from Australia, Ireland and France [37–39]." exact="Primary" post="or elementary school children aged 6–11 years were less"/>
 <result pre="group in Germany using two different PCR systems to assess" exact="viral" post="load, determined that children under the age of 19"/>
 <result pre="age of 19 produce virtually the same average levels of" exact="viral" post="RNA as adults [41]. Another study from Chicago showed"/>
 <result pre="5 years had tenfold to 100-fold greater amount of SARS-CoV-2" exact="viral" post="RNA, which correlates with infectious virus [42], in their"/>
 <result pre="100-fold greater amount of SARS-CoV-2 viral RNA, which correlates with" exact="infectious" post="virus [42], in their upper respiratory tracts compared with"/>
 <result pre="viral RNA, which correlates with infectious virus [42], in their" exact="upper" post="respiratory tracts compared with older children aged 5–17 years"/>
 <result pre="RNA, which correlates with infectious virus [42], in their upper" exact="respiratory" post="tracts compared with older children aged 5–17 years or"/>
 <result pre="[43]. Sampling bias due to the increased possibility of asymptomatic" exact="infection" post="in children that reduces the chances of being tested"/>
 <result pre="children that reduces the chances of being tested early in" exact="infection" post="when virus levels in the nasopharynx are high, could"/>
 <result pre="could explain the disparity in results from different studies. Since" exact="viral" post="RNA levels in the feces remain high for more"/>
 <result pre="three weeks after the onset of symptoms in contrast to" exact="viral" post="RNA in the nose and saliva that decline drastically"/>
 <result pre="1–2 weeks, analyzing stool samples for transmissible virus from mildly" exact="symptomatic" post="and asymptomatic children could provide the experimental data to"/>
 <result pre="could provide the experimental data to validate this argument [44]." exact="Viral" post="replication in the GI tract and prolonged fecal shedding"/>
 <result pre="to SARS-CoV-2, will help determine the incidence of novel coronavirus" exact="infection" post="in children in the USA and whether rates differ"/>
 <result pre="the USA and whether rates differ between children who have" exact="asthma" post="or other allergic conditions and children who do not"/>
 <result pre="of schools in the fall The new US Centers for" exact="Disease" post="Control and Prevention (CDC) guidelines on education and child"/>
 <result pre="to be infected than adults (at least based on nasopharyngeal" exact="viral" post="RNA detection as discussed in the previous subsection), and"/>
 <result pre="be considered carefully, with continuous monitoring of possible resurgence in" exact="infections" post="through frequent testing and isolation of infected – and"/>
 <result pre="and isolation of infected – and perhaps more importantly of" exact="infectious" post="– students, educators and other staff, for their safety"/>
 <result pre="safety and wellbeing of their families. The current Centers for" exact="Disease" post="Control and Prevention guidelines do not recommend universal screenings"/>
 <result pre="caregivers to monitor their children every day for ‘signs of" exact="infectious" post="illness’, most likely referring to symptoms that, if present"/>
 <result pre="distancing considering the recent advances in the biophysics of host-to-host" exact="respiratory" post="disease transmission, respiratory etiquette and masks for older children."/>
 <result pre="considering the recent advances in the biophysics of host-to-host respiratory" exact="disease" post="transmission, respiratory etiquette and masks for older children. Such"/>
 <result pre="recent advances in the biophysics of host-to-host respiratory disease transmission," exact="respiratory" post="etiquette and masks for older children. Such mitigation measures"/>
 <result pre="older children. Such mitigation measures would also help contain other" exact="respiratory" post="infections in the community. Alternative plans for virtual learning"/>
 <result pre="children. Such mitigation measures would also help contain other respiratory" exact="infections" post="in the community. Alternative plans for virtual learning should"/>
 <result pre="direct and indirect benefit given that children may contribute to" exact="adult" post="infections and develop life-threatening disease themselves, is that vaccine"/>
 <result pre="and indirect benefit given that children may contribute to adult" exact="infections" post="and develop life-threatening disease themselves, is that vaccine development"/>
 <result pre="that children may contribute to adult infections and develop life-threatening" exact="disease" post="themselves, is that vaccine development efforts for COVID-19 should"/>
 <result pre="Med.382(13), 1199–1207 (2020).31995857 2.collab: The World Heath Organization (WHO). Coronavirus" exact="disease" post="2019 (COVID-19): situation report, 51. https://apps.who.int/iris/handle/10665/331475 3.BosmanJW.H.O. warns of"/>
 <result pre="York Times (2020). http://www.nytimes.com/2020/06/19/us/coronavirus-new-dangerous-phase.html 4.ZhouP , YangXL , WangXGet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="YuanSet al.Simulation of the clinical and pathological manifestations of coronavirus" exact="disease" post="2019 (COVID-19) in golden Syrian hamster model: implications for"/>
 <result pre="disease 2019 (COVID-19) in golden Syrian hamster model: implications for" exact="disease" post="pathogenesis and transmissibility. Clin. Infect. Dis. (2020) (Epub ahead"/>
 <result pre="(Epub ahead of print). 12.MunsterVJ , FeldmannF , WilliamsonBNet al.Respiratory" exact="disease" post="in rhesus macaques inoculated with SARS-CoV-2. Nature (2020) (Epub"/>
 <result pre="hamsters. Nature583, 834–838 (2020).32408338 14.OreshkovaN , MolenaarRJ , VremanSet al.SARS-CoV-2" exact="infection" post="in farmed minks, The Netherlands, April and May 2020."/>
 <result pre="(2020) (Epub ahead of print). 16.collab: Advisory Board on Cat" exact="Diseases" post="(ABCD). European advisory board on cat diseases. SARS-coronavirus (CoV)-2"/>
 <result pre="1200–1204 (2020).32555424 19.HeX , LauEHY , WuPet al.Temporal dynamics in" exact="viral" post="shedding and transmissibility of COVID-19. Nat. Med.26(5), 672–675 (2020).32296168"/>
 <result pre="of COVID-19. Nat. Med.26(5), 672–675 (2020).32296168 20.BourouibaLTurbulent gas clouds and" exact="respiratory" post="pathogen emissions: potential implications for reducing transmission of COVID-19."/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet395(10223), 507–513 (2020).32007143"/>
 <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA323(11), 1061–1069 (2020). 27.LudvigssonJFSystematic review of"/>
 <result pre="1088–1095 (2020).32202343 28.NakraNA , BlumbergDA , Herrera-GuerraA , LakshminrusimhaSMulti-system inflammatory" exact="syndrome" post="in children (MIS-C) following SARS-CoV-2 infection: review of clinical"/>
 <result pre="J. Med. Virol. (2020). 36.FontanetA , GrantR , TondeurLet al.SARS-CoV-2" exact="infection" post="in primary schools in northern France: a retrospective cohort"/>
 <result pre="Virol. (2020). 36.FontanetA , GrantR , TondeurLet al.SARS-CoV-2 infection in" exact="primary" post="schools in northern France: a retrospective cohort study in"/>
 <result pre=", CaseyG , KellyC , KellyD , McDarbyGNo evidence of" exact="secondary" post="transmission of COVID-19 from children attending school in Ireland,"/>
 <result pre="2000903 (2020). 38.DanisK , EpaulardO , BenetTet al.Cluster of coronavirus" exact="disease" post="2019 (Covid-19) in the French Alps, 2020. Clin. Infect."/>
 <result pre="http://ncirs.org.au/sites/default/files/2020-04/NCIRS%20NSW%20Schools%20COVID_Summary_FINAL%20public_26%20April%202020.pdf 40.ParkYJ , ChoeYJ , ParkOet al.Contact tracing during coronavirus" exact="disease" post="outbreak, South Korea, 2020. Emerg. Infect. Dis.26(10), (2020). 41.JonesTC"/>
 <result pre="(2020). 41.JonesTC , MühlemannB , VeithTet al.An analysis of SARS-CoV-2" exact="viral" post="load by patient age. medRxiv.2020.2006.2008.20125484 (2020) (Epub ahead of"/>
 <result pre=", PignyF , KaiserL , EckerleICulture-competent SARS-CoV-2 in nasopharynx of" exact="symptomatic" post="neonates, children, and adolescents. Emerg. Infect. Dis.26(10), (2020). 43.Heald-SargentT"/>
 <result pre=", RippeJ , PatelAB , KociolekLKAge-related differences in nasopharyngeal severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with"/>
 <result pre="RippeJ , PatelAB , KociolekLKAge-related differences in nasopharyngeal severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild"/>
 <result pre=", PatelAB , KociolekLKAge-related differences in nasopharyngeal severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) levels in patients with mild to"/>
 <result pre="2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus" exact="disease" post="2019 (COVID-19). JAMA Pediatr. (2020) (Epub ahead of print)."/>
 <result pre="44.HanMS , SeongMW , KimNet al.Viral RNA load in mildly" exact="symptomatic" post="and asymptomatic children with COVID-19, Seoul. Emerg. Infect. Dis.26(10),"/>
 <result pre="Infect. Dis.26(10), (2020). 45.collab: The National Institute of Allergy and" exact="Infectious" post="Diseases (NIAID). COVID-19: Human Epidemiology and Response to SARS-CoV-2"/>
 <result pre="Dis.26(10), (2020). 45.collab: The National Institute of Allergy and Infectious" exact="Diseases" post="(NIAID). COVID-19: Human Epidemiology and Response to SARS-CoV-2 (HEROS)."/>
</results>
